Its potential utility lies in providing a non-invasive, quantitative score that may enhance early HCC detection, particularly for smaller nodules or when AFP levels are non-diagnostic, thereby facilitating timely access to potentially curative treatments. This evidence concerns the gene AFP and hepatocellular carcinoma.